Alteration of contractile force and mass in the senescent diaphragm with β2-agonist treatment

Wesley N. Smith, Amie Dirks, Takao Sugiura, Susan Muller, Phillip Scarpace, Scott K. Powers

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Aging is associated with a decrease in diaphragmatic maximal tetanic force production (Po) in senescent rats. Treatment with the β2-agonist clenbuterol (CB) has been shown to increase skeletal muscle mass and Po in weak locomotor skeletal muscles from dystrophic rodents. It is unknown whether CB can increase diaphragmatic mass and Po in senescent rats. Therefore, we tested the hypothesis that CB treatment will increase specific Po (i.e., force per cross-sectional area) and mass in the diaphragm of old rats. Young (5 mo) and old (23 mo) male Fischer 344 rats were randomly assigned to one of the following groups (n = 10/group): 1) young CB treated; 2) young control; 3) old CB treated; and 4) old control. Animals were injected daily with either CB (2 mg/kg) or saline for 28 days. CB increased (P < 0.05) the mass of the costal diaphragm in both young and old animals. CB treatment increased diaphragmatic-specific Po in old animals (∼15%; P < 0.05) but did not alter (P > 0.05) diaphragmatic-specific Po in young animals. Biochemical analysis indicated that the improved maximal specific Po in the diaphragm of CB-treated old animals was not due to increased myofibrillar protein concentration. Analysis of the myosin heavy chain (MHC) content of the costal diaphragm revealed a CB-induced increase (P < 0.05) in type IIb MHC and a decrease in type I, IIa, and IIx MHC in both young and old animals. These data support the hypothesis that CB treatment can restore the age-associated decline in both diaphragmatic-specific Po and muscle mass.

Original languageEnglish (US)
Pages (from-to)941-948
Number of pages8
JournalJournal of applied physiology
Volume92
Issue number3
DOIs
StatePublished - 2002

Keywords

  • Clenbuterol
  • Myosin heavy chain
  • Sarcopenia

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Alteration of contractile force and mass in the senescent diaphragm with β<sub>2</sub>-agonist treatment'. Together they form a unique fingerprint.

Cite this